Australia markets closed

Purple Biotech Ltd (PPBT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.4900-0.0100 (-2.00%)
As of 03:00PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
17,034
17,034
16,320
11,827
7,238
Selling general and administrative
4,842
4,842
5,962
5,821
5,708
Total operating expenses
22,271
22,271
22,603
17,934
13,239
Operating income or loss
-22,271
-22,271
-22,603
-17,934
-13,239
Interest expense
56
56
67
79
56
Total other income/expenses net
4,001
4,001
307
-133
-15,660
Income before tax
-19,977
-19,977
-21,760
-17,826
-28,701
Income tax expense
-
-
-
0
0
Income from continuing operations
-19,977
-19,977
-21,760
-17,826
-28,701
Net income
-19,880
-19,880
-21,668
-18,384
-27,999
Net income available to common shareholders
-19,880
-19,880
-21,668
-18,384
-27,999
Basic EPS
-1.05
-
-12.00
-10.50
-2.38
Diluted EPS
-1.05
-
-12.00
-10.50
-2.38
Basic average shares
20,274
-
1,808
1,757
11,500
Diluted average shares
20,274
-
1,808
1,757
11,500